Detalhe da pesquisa
1.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med
; 387(12): 1089-1098, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027570
2.
Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin.
Circulation
; 147(25): 1902-1918, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37128901
3.
Turicibacter faecis sp. nov., isolated from faeces of heart failure mouse model.
Int J Syst Evol Microbiol
; 74(5)2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38722758
4.
Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial).
Cardiovasc Drugs Ther
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727896
5.
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 146(16): 1210-1224, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029465
6.
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
Ann Intern Med
; 175(6): 820-830, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467935
7.
Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779.
Circulation
; 143(23): 2277-2292, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33757294
8.
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF.
Circulation
; 143(20): 1962-1972, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33832352
9.
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.
Circulation
; 143(4): 298-309, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33040613
10.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med
; 381(21): 1995-2008, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31535829
11.
The CR9 element is a novel mechanical load-responsive enhancer that regulates natriuretic peptide genes expression.
FASEB J
; 35(4): e21495, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689182
12.
Aberrant accumulation of TMEM43 accompanied by perturbed transmural gene expression in arrhythmogenic cardiomyopathy.
FASEB J
; 35(11): e21994, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674311
13.
Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers.
Cardiovasc Drugs Ther
; 2022 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715526
14.
Do We Really Need Aspirin Loading for STEMI?
Cardiovasc Drugs Ther
; 36(6): 1221-1238, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35171384
15.
Daily self-monitoring of blood pressure decreases systolic and diastolic blood pressure in hypertensive participants.
Heart Vessels
; 37(7): 1265-1270, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091786
16.
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
Circulation
; 141(2): 90-99, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736335
17.
In vivo real-time ATP imaging in zebrafish hearts reveals G0s2 induces ischemic tolerance.
FASEB J
; 34(2): 2041-2054, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31916304
18.
Esm1 and Stc1 as Angiogenic Factors Responsible for Protective Actions of Adipose-Derived Stem Cell Sheets on Chronic Heart Failure After Rat Myocardial Infarction.
Circ J
; 85(5): 657-666, 2021 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33716265
19.
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).
Eur Heart J
; 41(36): 3402-3418, 2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820334
20.
Mutant KCNJ3 and KCNJ5 Potassium Channels as Novel Molecular Targets in Bradyarrhythmias and Atrial Fibrillation.
Circulation
; 139(18): 2157-2169, 2019 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30764634